Concepedia

Jennifer Hellawell

JH

17

Publications

1.6K

Citations

15

H-Index

2006

Active since

Affiliations

Orange County Research Center(Current)

Amgen (United States)

The University of Western Australia

Arrowhead Pharmaceuticals (United States)

Miami-Dade County Public Schools

Jennifer Hellawell is an author at Orange County Research Center specializing in medicine, cardiology, and heart failure.

ORCID

Top concepts

Publications per year

2006–2025

17

Publications

17

Preclinical development and phase 1 trial of a novel siRNA targeting lipoprotein(a)

Michael J. Koren, Patrick M. Moriarty, Seth J. Baum et al. · Nature Medicine · 2022 · 218 citations

, , +6

Synthesis, Activity, and Pharmacophore Development for Isatin-β-thiosemicarbazones with Selective Activity toward Multidrug-Resistant Cells

Matthew D. Hall, Noeris K. Salam, Jennifer Hellawell et al. · Journal of Medicinal Chemistry · 2009 · 165 citations · Full text

Occurrence of Clinically Diagnosed Hypertrophic Cardiomyopathy in the United States

Martin S. Maron, Jennifer Hellawell, Jaime C. Lucove et al. · The American Journal of Cardiology · 2016 · 163 citations

, , +2

Zodasiran, an RNAi Therapeutic Targeting ANGPTL3, for Mixed Hyperlipidemia

Robert S. Rosenson, Daniel Gaudet, Robert A. Hegele et al. · New England Journal of Medicine · 2024 · 157 citations

Plozasiran, an RNA Interference Agent Targeting APOC3, for Mixed Hyperlipidemia

Christie M. Ballantyne, Szilárd Vasas, Masoud Azizad et al. · New England Journal of Medicine · 2024 · 151 citations

Rows per page

1–5 of 17